These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

130 related articles for article (PubMed ID: 10092150)

  • 1. Prostate specific membrane antigen (PSM) is expressed in various human tissues: implication for the use of PSM reverse transcription polymerase chain reaction to detect hematogenous prostate cancer spread.
    Renneberg H; Friedetzky A; Konrad L; Kurek R; Weingärtner K; Wennemuth G; Tunn UW; Aumüller G
    Urol Res; 1999; 27(1):23-7. PubMed ID: 10092150
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Prostate-specific membrane antigen-derived primers in a nested reverse transcription polymerase chain reaction for detecting prostatic cancer cells.
    Saimoto A; Saito S; Murai M
    Jpn J Cancer Res; 1999 Feb; 90(2):233-9. PubMed ID: 10189895
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Value of reverse transcription polymerase chain reaction assay in pathological stage T3N0 prostate cancer.
    Okegawa T; Noda H; Kato M; Miyata A; Nutahara K; Higashihara E
    Prostate; 2000 Aug; 44(3):210-8. PubMed ID: 10906737
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Combined nested reverse transcription-PCR assay for prostate-specific antigen and prostate-specific membrane antigen in detecting circulating prostatic cells.
    Zhang Y; Zippe CD; Van Lente F; Klein EA; Gupta MK
    Clin Cancer Res; 1997 Jul; 3(7):1215-20. PubMed ID: 9815802
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Molecular staging of prostate cancer: comparison of nested reverse transcription polymerase chain reaction assay using prostate specific antigen versus prostate specific membrane antigen as primer.
    Okegawa T; Yoshioka J; Morita R; Nutahara K; Tsukada Y; Higashihara E
    Int J Urol; 1998 Jul; 5(4):349-56. PubMed ID: 9712443
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Expression of prostate-specific antigen and prostate-specific membrane antigen transcripts in blood cells: implications for the detection of hematogenous prostate cells and standardization.
    Gala JL; Heusterspreute M; Loric S; Hanon F; Tombal B; Van Cangh P; De Nayer P; Philippe M
    Clin Chem; 1998 Mar; 44(3):472-81. PubMed ID: 9510850
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The expression of prostate-specific membrane antigen in peripheral blood leukocytes.
    Lintula S; Stenman UH
    J Urol; 1997 May; 157(5):1969-72. PubMed ID: 9112573
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Sensitive nested reverse transcription polymerase chain reaction detection of circulating prostatic tumor cells: comparison of prostate-specific membrane antigen and prostate-specific antigen-based assays.
    Israeli RS; Miller WH; Su SL; Powell CT; Fair WR; Samadi DS; Huryk RF; DeBlasio A; Edwards ET; Wise GJ
    Cancer Res; 1994 Dec; 54(24):6306-10. PubMed ID: 7527294
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Combined nested RT-PCR assay for prostate-specific antigen and prostate-specific membrane antigen in prostate cancer patients: correlation with pathological stage.
    Grasso YZ; Gupta MK; Levin HS; Zippe CD; Klein EA
    Cancer Res; 1998 Apr; 58(7):1456-9. PubMed ID: 9537248
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Detection of prostate-specific antigen- or prostate-specific membrane antigen-positive circulating cells in prostatic cancer patients: clinical implications.
    Millon R; Jacqmin D; Muller D; Guillot J; Eber M; Abecassis J
    Eur Urol; 1999 Oct; 36(4):278-85. PubMed ID: 10473985
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Detection of circulating tumor cells in patients with prostate cancer using prostate specific membrane-derived primers in the polymerase chain reaction.
    Noguchi M; Miyajima J; Itoh K; Noda S
    Int J Urol; 1997 Jul; 4(4):374-9. PubMed ID: 9256327
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Expression of prostate specific membrane antigen and three alternatively spliced variants of PSMA in prostate cancer patients.
    Schmittgen TD; Teske S; Vessella RL; True LD; Zakrajsek BA
    Int J Cancer; 2003 Nov; 107(2):323-9. PubMed ID: 12949815
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Enhanced detection of hematogenous circulating prostatic cells in patients with prostate adenocarcinoma by using nested reverse transcription polymerase chain reaction assay based on prostate-specific membrane antigen.
    Loric S; Dumas F; Eschwege P; Blanchet P; Benoit G; Jardin A; Lacour B
    Clin Chem; 1995 Dec; 41(12 Pt 1):1698-704. PubMed ID: 7497608
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The clinical utility of the prostate specific membrane antigen reverse-transcription/polymerase chain reaction to detect circulating prostate cells: an analysis in healthy men and women.
    Llanes L; Ferruelo A; Páez A; Gómez JM; Moreno A; Berenguer A
    BJU Int; 2002 Jun; 89(9):882-5. PubMed ID: 12010232
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Repetitive and site-specific molecular staging of prostate cancer using nested reverse transcriptase polymerase chain reaction for prostate specific antigen and prostate specific membrane antigen.
    Koutsilieris M; Lembessis P; Luu-The V; Sourla A
    Clin Exp Metastasis; 1999; 17(10):823-30. PubMed ID: 11089880
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Detection of prostatic specific membrane antigen messenger RNA using immunobead reverse transcriptase polymerase chain reaction.
    Ghossein RA; Osman I; Bhattacharya S; Ferrara J; Fazzari M; Cordon-Cardo C; Scher HI
    Diagn Mol Pathol; 1999 Jun; 8(2):59-65. PubMed ID: 10475379
    [TBL] [Abstract][Full Text] [Related]  

  • 17. High expression of PSM-E correlated with tumor grade in prostate cancer: a new alternatively spliced variant of prostate-specific membrane antigen.
    Cao KY; Mao XP; Wang DH; Xu L; Yuan GQ; Dai SQ; Zheng BJ; Qiu SP
    Prostate; 2007 Dec; 67(16):1791-800. PubMed ID: 17929272
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The use of real-time quantitative PCR to detect circulating prostate-specific membrane antigen mRNA in patients with prostate carcinoma.
    Chu DC; Chuang CK; Liou YF; Tzou RD; Lee HC; Sun CF
    Ann N Y Acad Sci; 2004 Jun; 1022():157-62. PubMed ID: 15251956
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Expression of prostatic factors measured by reverse transcription polymerase chain reaction in human papillomavirus type 18 deoxyribonucleic acid immortalized prostate cell lines.
    Weijerman PC; Zhang Y; Shen J; Dubbink HJ; Romijn JC; Peehl DM; Schröder FH
    Urology; 1998 Apr; 51(4):657-62. PubMed ID: 9586625
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Preoperative combined nested reverse transcriptase polymerase chain reaction for prostate-specific antigen and prostate-specific membrane antigen does not correlate with pathologic stage or biochemical failure in patients with localized prostate cancer undergoing radical prostatectomy.
    Thomas J; Gupta M; Grasso Y; Reddy CA; Heston WD; Zippe C; Dreicer R; Kupelian PA; Brainard J; Levin HS; Klein EA
    J Clin Oncol; 2002 Aug; 20(15):3213-8. PubMed ID: 12149293
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.